Investigational Site Number :0760004

São Paulo, São Paulo 4023-062

0 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Plasma Cell Myeloma

Studies at this site

• Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia — Stopped early
• Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Completed